Legal & General Group’s Pliant Therapeutics PLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-52,961
| Closed | -$71.7K | – | 3506 |
|
|
2025
Q1 | $71.7K | Hold |
52,961
| – | – | ﹤0.01% | 2691 |
|
|
2024
Q4 | $697K | Buy |
52,961
+12,249
| +30% | +$161K | ﹤0.01% | 2347 |
|
|
2024
Q3 | $456K | Buy |
40,712
+333
| +0.8% | +$3.73K | ﹤0.01% | 2496 |
|
|
2024
Q2 | $434K | Sell |
40,379
-1,246
| -3% | -$13.4K | ﹤0.01% | 2465 |
|
|
2024
Q1 | $620K | Sell |
41,625
-109
| -0.3% | -$1.62K | ﹤0.01% | 2347 |
|
|
2023
Q4 | $756K | Sell |
41,734
-184
| -0.4% | -$3.33K | ﹤0.01% | 2304 |
|
|
2023
Q3 | $727K | Sell |
41,918
-418
| -1% | -$7.25K | ﹤0.01% | 2299 |
|
|
2023
Q2 | $767K | Buy |
42,336
+25,229
| +147% | +$457K | ﹤0.01% | 2312 |
|
|
2023
Q1 | $455K | Buy |
17,107
+7,381
| +76% | +$196K | ﹤0.01% | 2339 |
|
|
2022
Q4 | $188K | Buy |
+9,726
| New | +$188K | ﹤0.01% | 2633 |
|
|
2022
Q2 | – | Sell |
-5,792
| Closed | -$41K | – | 3622 |
|
|
2022
Q1 | $41K | Hold |
5,792
| – | – | ﹤0.01% | 3034 |
|
|
2021
Q4 | $78K | Buy |
5,792
+36
| +0.6% | +$485 | ﹤0.01% | 2957 |
|
|
2021
Q3 | $97K | Buy |
5,756
+2,454
| +74% | +$41.4K | ﹤0.01% | 2855 |
|
|
2021
Q2 | $96K | Sell |
3,302
-17
| -0.5% | -$494 | ﹤0.01% | 2752 |
|
|
2021
Q1 | $131K | Buy |
3,319
+2,177
| +191% | +$85.9K | ﹤0.01% | 2545 |
|
|
2020
Q4 | $26K | Hold |
1,142
| – | – | ﹤0.01% | 2991 |
|
|
2020
Q3 | $26K | Sell |
1,142
-3,858
| -77% | -$87.8K | ﹤0.01% | 2898 |
|
|
2020
Q2 | $161K | Buy |
+5,000
| New | +$161K | ﹤0.01% | 2406 |
|